Candida Infective Endocarditis: an Observational Cohort Study with a Focus on Therapy
Christopher J Arnold, Melissa Johnson, Arnold S Bayer, Suzanne Bradley, Efthymia Giannitsioti, Jose M Miro, Pilar Tornos, Pierre Tattevin, Jacob Strahilevitz, Denis Spelman, Eugene Athan, Francisco Nacinovich, Claudio Q Fortes, Cristiane Lamas, Bruno Barsic, Nuria Fernandez-Hidalgo, Patricia Munoz, Vivian H Chu
Antimicrobial Agents and Chemotherapy | AMER SOC MICROBIOLOGY | Published : 2015
Awarded by American Heart Association (AHA)
Awarded by NIH
Funding for this study was provided, in part, by the American Heart Association (AHA 0675027N) and an educational grant from Merck (Vivian H. Chu).Melissa Johnson receives research support from Charles River Laboratories, Astellas Pharma US, and WHISCON as well as royalties from UpToDate. Arnold S. Bayer receives research funding from Cubist Pharmaceuticals, Contrafect Pharmaceuticals, and Theravance Pharmaceuticals and a grant from the NIH (NIH-NIAID RO-1). Pierre Tattevin receives travel grants from Astellas, Gilead, MSD, and Pfizer. Bruno Barsic is on the Board of Speakers for Pfizer, MSD, Astellas, and Pliva. Jose Miro receives consulting honoraria and research grants from AbbVie, Bristol Myers Squibb, Cubist, Novartis, Gilead, Pfizer, and ViiV.